Related Experiment Videos
Model insomnia, noise, and methylphenidate, used for the evaluation of hypnotic drugs
Abstract:
Experimental sleep disturbance (model insomnia) was produced by intermittent white noise and the administration of 10 mg of methylphenidate (MPD). The effects of flurazepam (FZP) 15 mg and triazolam (TZM) 0.25 mg on these models was investigated. All night sleep polygraphy was performed on 8 normal male subjects under each of the following 9 conditions: baseline, TZM 0.25 mg, FZP 15 mg, white noise alone, noise and TZM, noise and FZP, MPD alone, MPD and TZM, and MPD and FZP. A reduction in total sleep time and stage were (S-REM) and an increase in the wakening stage were observed with both noise and MPD. Stage 4 sleep was reduced only by MPD. Administration of TZM or EZP did not cause any significant change in sleep parameters. These drugs in combination with noise or MPD resulted in almost complete recovery of the sleep disturbance induced by noise or MPD, except for a reduction in S-REM. These results indicate that model insomnia, particularly MPD insomnia, will assist in the evaluation of hypnotic drugs.
Insights
This study investigated how flurazepam and triazolam affect sleep disturbance models. These hypnotics helped recover sleep disrupted by noise or methylphenidate, showing potential for evaluating new sleep medications.
Area of Science:
- Pharmacology
- Sleep Medicine
- Neuroscience
Background:
- Experimental models are crucial for understanding sleep disturbances.
- Methylphenidate (MPD) and white noise can induce insomnia-like symptoms.
- Benzodiazepines like flurazepam (FZP) and triazolam (TZM) are commonly used hypnotics.
Purpose of the Study:
- To investigate the effects of flurazepam (FZP) and triazolam (TZM) on experimental sleep disturbance models.
- To evaluate the efficacy of FZP and TZM in counteracting sleep disruption caused by white noise and MPD.
- To assess the utility of these models for evaluating hypnotic drug effectiveness.
Main Methods:
- Eight healthy male subjects underwent all-night polysomnography under nine conditions.
- Conditions included baseline, individual drug administration (FZP, TZM), noise exposure, MPD administration, and combined challenges.
- Sleep parameters such as total sleep time, sleep stages (including S-REM and Stage 4), and wakefulness were monitored.
Main Results:
- Both white noise and MPD significantly reduced total sleep time and S-REM sleep, while increasing wakefulness.
- MPD uniquely decreased Stage 4 sleep.
- Neither FZP nor TZM alone altered sleep parameters significantly.
- Combined administration of FZP or TZM with noise or MPD largely reversed the induced sleep disturbances, except for S-REM sleep reduction.
Conclusions:
- Experimental models of insomnia, particularly those induced by MPD, are effective for evaluating hypnotic drug efficacy.
- Flurazepam and triazolam demonstrate significant restorative effects on sleep disrupted by noise and MPD.
- These findings support the use of MPD-induced insomnia as a valuable model for preclinical assessment of new hypnotics.